- Investing.com
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Metrics to compare | TECN | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipTECNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −14.5x | 23.4x | −0.4x | |
PEG Ratio | 0.05 | 1.03 | 0.00 | |
Price/Book | 1.4x | 2.9x | 2.6x | |
Price / LTM Sales | 1.8x | 3.3x | 3.2x | |
Upside (Analyst Target) | 29.9% | 26.1% | 46.7% | |
Fair Value Upside | Unlock | 13.4% | 7.6% | Unlock |